drugset
drugset / Trial / NCT04992013

Niraparib in Tumors Metastatic to the CNS

NCT04992013 ↗

Phase 2 Active not recruiting 20 enrolled Massachusetts General Hospital GlaxoSmithKline · collab
NaSingle-groupOpen-labelTreatment

Summary

This research is being done to see how effective the drug niraparib is against cancer that has metastasized to the central nervous system (CNS). * This research study involves the study drug niraparib.

Timeline

Start
2022-04-05
Primary completion
2026-12-01
Completion
2027-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Niraparib Small molecule — Oral

Indications

central nervous system cancer metastatic malignant neoplasm